CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

208 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q4 2024.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92.8M shares of 417M outstanding shares and own 22.27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (19.6M shares), RENAISSANCE TECHNOLOGIES LLC (11.1M shares), BlackRock, Inc. (10M shares), GEODE CAPITAL MANAGEMENT, LLC (4.88M shares), Qube Research & Technologies Ltd (4.71M shares), PNC Financial Services Group, Inc. (4.47M shares), MARSHALL WACE, LLP (3.77M shares), STATE STREET CORP (2.8M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.75M shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.74M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.